83257-0003 OGIVRI - CanMED: NDC

Product NDC:

83257-0003

Brand Name:

OGIVRI

Generic Name:

Trastuzumab-dkst

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 420.0

Unit: mg/20mL

Packages:

Code: 83257-0003-01

Description: 1 VIAL, MULTI-DOSE in 1 CARTON (83257-003-01) / 20 mL in 1 VIAL, MULTI-DOSE

Effective Date: Oct. 1, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox